Introduction
As a master regulator of the DNA damage response, ataxia telangiectasia mutated (ATM) kinase is rapidly activated by DNA doublestrand breaks and phosphorylates substrates involved in both DNA repair and checkpoint control. Loss of ATM causes ataxiatelangiectasia (A-T) syndrome characterized by primary immunodeficiency and greatly increased risk for lymphoid malignancies, especially of T-cell lineage. 1 Moreover, .50% of T-cell prolymphoblastic leukemia (T-PLL) patients carry a somatic mutation of ATM.
2 Both T-PLL and A-T patients carry inv (14;14) that involves the T-cell receptor a/d (TCRa/d) and immunoglobulin H loci on human chromosome 14. However, the molecular origin of the seemingly T-cell-specific lymphocytopenia and inv (14;14) remains unknown. ATM 2/2 mice recapitulate the T-cell lymphocytopenia of A-T patients and succumb to thymic lymphomas with TCRa/d-related chromosome 14 amplification and t (12;14) translocations, syntenic with inv (14;14) in humans. 3 Reduced ab T-cell numbers and blockade at the double-positive (DP) to single-positive (SP) transition is characteristic of ATM-deficient T cells. 4, 5 Both human and mouse TCRd loci reside between Va and Ja segments. 6 As such, TCRa rearrangement deletes the TCRd gene, leading to irreversible commitment to the ab T-cell lineage. This stage-specific rearrangement of the TCRd in double-negative (DN) and TCRa in DP T cells is driven by the loci-specific enhancer elements Ed and Ea, respectively. 6, 7 However, Ea deletion does not affect the kinetics or translocation patterns of ATM-deficient thymic lymphomas, 3 suggesting that TCRd might be involved. In this context, TCRd-related translocations are found in the majority of T-ALL and .90% of TAL1 translocated cases. 8 Using ATM 2/2 Ed 2/2 mice, here we identified aberrant TCRd rearrangements as the origin for both ab T-cell development defects and the recurrent t(12;14) translocations in ATM-deficient mice.
Study design
All animal work was conducted with proof from the institutional Animal Care and Use Committee of Columbia University. ATM 2/29 and Ed 2/210 mice were described previously. T-cell development was characterized in 4-to 6-week-old mice as previously described. 11 Briefly, single-cell suspensions of thymus and spleen were counted and stained with fluorophore-conjugated antibodies against CD4, CD8, CD3, TCRb, or TCRg. For DN staining, thymocytes were counterstained with phycoerythrin-conjugated anti-CD4, CD8, B220, TCRgd, Ter119 and CD19 antibodies, then with fluorophoreconjugated anti-CD44 and anti-CD25 antibodies. Flow cytometry data were collected on FACSCalibur (BD) and analyzed with FlowJo. For cytogenetic analyses, single cell suspensions were incubated with colcemid (10 mg/mL) for 4 to 10 hours and fixed and stained 3 using ASI applied spectral imaging paints. Images were acquired and analyzed with Isis and Metafer 4 (MetaSystems, Newton, MA). Comparative genomic hybridization (CGH) was performed with the Agilent 244K mouse array. Reverse-transcription polymerase chain reaction (PCR) methods are detailed in Figure 2F and supplemental Table 1 (available on the Blood Web site). . 10 ATM is particularly important for inversional V(D)J recombination, 12 and Vd5 is located downstream of Cd and requires inversional rearrangement. 13 The configuration of the TCRa/d locus also determines that if DNA breaks in the TCRd loci are unrepaired, then Ea would separate from Vas and disable TCRa V(D)J recombination ( Figure 2C ). These findings reveal an important role of genomic instability at the TCRd locus in ab T-cell development and T-cell lymphocytopenia associated with ATM deficiency, and they suggest that suppression of TCRd rearrangement might improve T-cell counts in A-T patients.
Results and discussion
Despite improved T-cell counts, the kinetics of succumbing to thymic lymphomas was similar in ATM Figure 2C ). Southern blot further confirmed that all 3 tumors (497, 713, and 745) rearranged the proximal Ja segments ( Figure 2C ). Thus, TCRd rearrangement is not required for 6 ). Data represent the average 6 standard deviation from at least 5 independent mice of each genotype (see supplemental Figure 1A for details). The P values between 2 genotypes were calculated based on the 2-tailed Student t test assuming unequal variance. Supplemental Figure 1B summarizes the P value from pairwise comparison for total, DP, and SP thymocytes between different genotypes. Ed 2/2 thymic lymphomas as well as wild-type total thymus, and dissolved in 100 mL DEPC-H2O and verified to have A 260 nm/280 nm between 1.8 and 2. Approximately 5 mg of total RNA was treated with RNase-free DNase I (Roche). The DNaseI activity was abolished by the addition of 2 mL of 25-mM EDTA and incubation at 65°C for 15 minutes. Reverse transcription was performed using SuperScript III reverse transcriptase (Invitrogen) and Oligod(T)18 (New England Biolabs) according to the manufacturer's instructions. The resulted complementary DNA was dissolved in TE and quantified with NanoDrop (Thermo Scientific). Quantitative PCR was then performed with gene-specific primers (supplemental Table 1 Figure 2D and supplemental Figure 2B ) and also revealed a unique hemizygous deletion of chromosome 14 downstream of the TCRa/d locus only in Cd-negative (497 and 745) tumors ( Figure 2D and supplemental Figure 2B ). CGH probe mapping showed that the deletion started at the proximal Ja ( Figure 2C-D) .
Together with the absence of the t(12;14) translocation, this result suggests that when chromosome 14 amplification occurs in DP T cells during TCRa arrangement, the break in chromosome 12 is no longer available to form the t(12;14) translocation, causing the telomeric portion of chromosome 14 to be lost and pointing to concurrent immunoglobulin H and TCRd rearrangement in DN T cells as the molecular origin for t (12;14) . This further implied that t (12;14) and the syntenic inv (14, 14) are not essential for T-cell transformation. Despite the lack of t(12;14), both Cd-negative (497 and 745) tumors displayed hemizygous deletion of chromosome 12 telomeric regions, supporting the existence of potential tumor-suppressor genes (eg, Bcl11b). 3, [14] [15] [16] In this context, SKY analyses identified t(12;15) translocations involving chromosome 15 in tumor 745 ( Figure 2B and supplemental Figure 2C ). Finally, CGH also indicated that murine ATM 2/2 thymic lymphomas, regardless of Ed status, display genetic changes that have been associated with human T-cell acute lymphoblastic leukemia (T-ALL), including trisomy of chromosome 15 containing c-Myc, amplification and overexpression of Notch1, deletion of Pten, and overexpression of IL7R ( Figure 2F ), highlighting ATM-deficient murine thymic lymphomas as a bona fide animal model for human T-ALL. In summary, our study identifies aberrant TCRd rearrangement in the absence of ATM together with the unique configurations of the TCRa/d locus as one of the major causes to both T-cell-specific lymphocytopenia and the t(12;14) and related inv(14;14) associated with ATM deficiency and potentially in other T-ALL.
